Vincent Remouchamps
About
Vincent Remouchamps is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Vincent Remouchamps has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiation, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vincent Remouchamps's work include Advanced Radiotherapy Techniques (27 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Vincent Remouchamps is often cited by papers focused on Advanced Radiotherapy Techniques (27 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Vincent Remouchamps collaborates with scholars based in Belgium, United States and France. Vincent Remouchamps's co-authors include John Wong, Frank A. Vicini, Larry L. Kestin, Alvaro A. Martinez, Michael B. Sharpe, Nicola Letts, J Fayad, Philip Poortmans, Caroline Weltens and Kathy Baglan and has published in prestigious journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.
In The Last Decade
Vincent Remouchamps
45 papers receiving 2.3k citations
Hit Papers
Peers
Vincent Remouchamps
Gabriele Simontacchi Italy
Christina Mitchell United States
Jacques Borger Netherlands
Martin Housset France
Marciana Nona Duma Germany
Katharina E. Sixel Canada
Jaroslaw T. Hepel United States
Robert C. Frazier United States
Vijay R. Kini United States
Richard C. Matter United States
Citations per year, relative to Vincent Remouchamps Vincent Remouchamps (= 1×)
peers
Gabriele Simontacchi
Countries citing papers authored by Vincent Remouchamps
Since
Specialization
Citations
This map shows the geographic impact of Vincent Remouchamps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Remouchamps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Remouchamps more than expected).
Fields of papers citing papers by Vincent Remouchamps
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Vincent Remouchamps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Remouchamps. The network helps show where Vincent Remouchamps may publish in the future.
Co-authorship network of co-authors of Vincent Remouchamps
This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Remouchamps. A scholar is included among the top collaborators of Vincent Remouchamps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Remouchamps. Vincent Remouchamps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Caluwé, Alex De, Kim Cao, Vincent Remouchamps, et al.. (2025). Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial. Radiotherapy and Oncology. 206. 110836–110836.
2.
Desmoulins, Isabelle, Emanuela Romano, Vincent Remouchamps, et al.. (2024). 2O TILs and PD-L1 early dynamics in the randomized Neo-CheckRay phase II trial evaluating neo-adjuvant immuno-radiation and adenosine pathway blockade for early-stage, high risk ER+/HER2- breast cancer (BC). Immuno-Oncology Technology. 24. 100886–100886.
3.
Caluwé, Alex De, Isabelle Desmoulins, Vincent Remouchamps, et al.. (2024). LBA10 Primary endpoint results of the Neo-CheckRay phase II trial evaluating stereotactic body radiation therapy (SBRT) +/- durvalumab (durva) +/- oleclumab (ole) combined with neo-adjuvant chemotherapy (NACT) for early-stage, high risk ER+/HER2- breast cancer (BC). Annals of Oncology. 35. S1205–S1205.
4.
Esch, A. Van, et al.. (2022). Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?. Reports of Practical Oncology & Radiotherapy. 27(3). 490–499.
5.
Houtte, P. Van, et al.. (2022). Radiation therapy-induced left vocal cord paralysis following lung stereotactic body radiation therapy: A case report and review of the literature. Cancer/Radiothérapie. 27(1). 69–74.
6.
Jansen, Nicolas, Caroline Weltens, Luigi Moretti, et al.. (2022). Radiotherapy-specific quality indicators at national level: How to make it happen. Radiotherapy and Oncology. 178. 109433–109433.
7.
Lievens, Yolande, et al.. (2021). ProCaLung – Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium☆. Radiotherapy and Oncology. 167. 57–64.
8.
Deseyne, Pieter, Chris Monten, Vincent Remouchamps, et al.. (2021). Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients. Scientific Reports. 11(1). 22529–22529.
9.
Ocak, Sebahat, et al.. (2019). Illustration of a fatal radiation-induced lung aneurysm: Is central lung stereotactic radiotherapy to be banned?. Cancer/Radiothérapie. 23(8). 926–929.
10.
Rondelet, Benoı̂t, Thierry Vander Borght, Myriam Remmelink, et al.. (2018). Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab. Lung Cancer. 128. 53–56.
11.
Christodoulou, Maria, Fiona Blackhall, Hitesh Mistry, et al.. (2018). Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial. Journal of Thoracic Oncology. 14(1). 63–71.
12.
Christodoulou, Maria, Fiona Blackhall, Linda Ashcroft, et al.. (2017). OA05.06 Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial. Journal of Thoracic Oncology. 12(1). S262–S263.
13.
Hanin, François‐Xavier, Benoît Ghaye, Aline van Maanen, et al.. (2017). An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging. Strahlentherapie und Onkologie. 193(10). 812–822.
14.
Offersen, Birgitte Vrou, Liesbeth Boersma, Carine Kirkove, et al.. (2015). ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiotherapy and Oncology. 114(1). 3–10.
15.
Langhe, Sofie De, Thomas Mulliez, Liv Veldeman, et al.. (2014). Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. BMC Cancer. 14(1). 711–711.
16.
Boehmer, Dirk, P. Maingon, Philip Poortmans, et al.. (2006). Guidelines for primary radiotherapy of patients with prostate cancer. Radiotherapy and Oncology. 79(3). 259–269.
17.
Machiels, J-P., Lionel Duck, Brigitte Honhon, et al.. (2005). Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Annals of Oncology. 16(12). 1898–1905.
18.
Scalliet, Pierre, Vincent Remouchamps, Desmond Curran, et al.. (2004). Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC. International Journal of Radiation Oncology*Biology*Physics. 58(5). 1549–1561.
19.
Scalliet, Pierre, Vincent Remouchamps, M. van Glabbeke, et al.. (2001). A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: survival and progression-free survival. Cancer/Radiothérapie. 5(3). 262–272.
20.
Claus, Filip, et al.. (2001). Evaluation of a leaf position optimization tool for intensity modulated radiation therapy of head and neck cancer. Radiotherapy and Oncology. 61(3). 281–286.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Gabriele Simontacchi Breakdown of academic impact, for papers by Christina Mitchell Breakdown of academic impact, for papers by Jacques Borger Breakdown of academic impact, for papers by Martin Housset Breakdown of academic impact, for papers by Marciana Nona Duma Breakdown of academic impact, for papers by Katharina E. Sixel Breakdown of academic impact, for papers by Jaroslaw T. Hepel Breakdown of academic impact, for papers by Robert C. Frazier Breakdown of academic impact, for papers by Vijay R. Kini Breakdown of academic impact, for papers by Richard C. Matter